← Back to Search

Hyaluronic Acid Dermal Filler

Infraorbital Filler for Dermal Filler

N/A
Waitlist Available
Led By Ivona Percec, MD, PhD
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
interested in filler injections to reduce undereye volume loss
Interested in filler injections to reduce undereye volume loss
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 0 pre-intervention, day 0 post-intervention, day 14, day 30, day 90
Awards & highlights

Study Summary

This trial tests how well a dermal filler (Juvéderm Volbella XC) works to reduce wrinkles and add volume to the under eye area. Patients return for 3D photography after 2 weeks, 1 month, and 3 months.

Eligible Conditions
  • Dermal Filler
  • Rejuvenation

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You want to get injections to reduce the loss of volume under your eyes.
Select...
You want to get filler injections to reduce the appearance of volume loss under your eyes.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 0 pre-intervention, day 0 post-intervention, day 14, day 30, day 90
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 0 pre-intervention, day 0 post-intervention, day 14, day 30, day 90 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Volumetric change in infraorbital treatment
Secondary outcome measures
Patient Satisfaction with validated the questionnaire FACE-Q

Side effects data

From undefined Phase 3 trial • 332 Patients • NCT01240382
1%
Eye irritation
1%
Gastrointestinal bleeding
100%
80%
60%
40%
20%
0%
Study treatment Arm
0.1% HA
3% DE-089

Trial Design

1Treatment groups
Experimental Treatment
Group I: Infraorbital FillerExperimental Treatment1 Intervention
Receives 1-2mL injection of approved filler in infraorbital region

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor
1,992 Previous Clinical Trials
42,875,828 Total Patients Enrolled
Ivona Percec, MD, PhDPrincipal InvestigatorPenn Medicine

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this study open to individuals who have yet to reach the age of sixty?

"Patients aged 22 and above, up until their 65th birthday, are being recruited for this medical trial."

Answered by AI

Am I able to partake in this clinical trial?

"12 participants are needed for this experiment, who must be between the ages of 22 and 65. Additionally, all potential enrollees should have dermal filler experience."

Answered by AI

Are there opportunities to enroll in this experiment now?

"According to the information found on clinicaltrials.gov, this trial is actively looking for volunteers and has seen recent updates since its initial posting date of June 1st 2023."

Answered by AI

What is the maximum capacity of research participants in this trial?

"Yes, the available evidence on clinicaltrials.gov indicates that this research is accepting participants. The trial was first made visible to the public 6 months ago and has undergone some revisions since then; 12 test subjects are needed from one medical centre."

Answered by AI
~6 spots leftby Mar 2025